{
    "clinical_study": {
        "@rank": "45340", 
        "biospec_descr": {
            "textblock": "whole blood, serum,plasma,PBMC"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The purpose of the study is to establish drug-induced liver injury databases in China, make\n      criteria for Chinese drug-induced liver injury patients and evaluate the application of\n      certain circulating miRNA in diagnosis or treatment of drug-induced liver injury."
        }, 
        "brief_title": "Establishment of Drug-induced Liver Injury Databases and Application of Circulating microRNA(miRNA)", 
        "completion_date": {
            "#text": "April 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Drug-induced Liver Injury", 
        "condition_browse": {
            "mesh_term": [
                "Drug-Induced Liver Injury", 
                "Wounds and Injuries"
            ]
        }, 
        "detailed_description": {
            "textblock": "Firstly, this study collects some retrospective data. Analyse these data and establish\n      certain unique diagnostic criteria for Chinese. Then collect prospective data and validate\n      the criteria. Otherwise,collect blood sample or other sample of the patients and study\n      certain miRNA in diagnosis or treatment of drug-induced liver injury."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Males and females between the age of 18 to 70 years\n\n          -  Women in child-bearing period taking some contraception measures\n\n          -  Patients with onset of acute liver injury attributed to antituberculosis drugs or\n             antineoplastic drugs, Roussel Uclaf Causality Assessment Method\uff08RUCAM \uff09 score\u22656\n\n          -  Written informed consent can be obtained, some patients agree with liver biopsy\n\n        Exclusion Criteria:\n\n          -  Viral hepatitis\n\n          -  Alcoholic liver disease or non-alcoholic liver disease\n\n          -  Wilson's disease or other inherited metabolic liver diseases\n\n          -  Auto-immune liver diseases\n\n          -  Any dysfunction of liver\n\n          -  Malnutrition\n\n          -  Chronic diseases such as HIV,severe heart diseases, severe brain diseases or chronic\n             kidney diseases\n\n          -  Patients who can not complete follow-ups on time"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "community sample and primary care clinic"
            }
        }, 
        "enrollment": {
            "#text": "800", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 26, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02061826", 
            "org_study_id": "Ditan-2014-01"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 15, 2014", 
        "location": {
            "contact": {
                "last_name": "Hong Zhao, master", 
                "phone": "+86 84322816"
            }, 
            "facility": {
                "address": {
                    "city": "Beijing", 
                    "country": "China", 
                    "zip": "100015"
                }, 
                "name": "Beijing Ditan Hospital"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "1", 
        "official_title": "Establishment of Drug-induced Liver Injury Databases and Application of Circulating miRNA", 
        "overall_contact": {
            "last_name": "Wen Xie, master", 
            "phone": "+86 84322816"
        }, 
        "overall_official": {
            "affiliation": "Beijing Ditan Hospital\uff0cCapital Medical University", 
            "last_name": "Wen Xie, master", 
            "role": "Study Director"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Liver biopsy is the main method", 
                "measure": "histological features of drug-induced liver injury obtained by liver biopsy", 
                "safety_issue": "No", 
                "time_frame": "within six months of the DILI onset date"
            }, 
            {
                "description": "serum parameters of liver function is the focus", 
                "measure": "clinical features of drug-induced liver injury assessed by serum parameters of liver function", 
                "safety_issue": "No", 
                "time_frame": "participants will be followed for the duration of hospital stay, an expected average of 3 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02061826"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Beijing Ditan Hospital", 
            "investigator_full_name": "Wen Xie", 
            "investigator_title": "head of department", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Beijing Ditan Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Beijing Ditan Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Observational Model: Case Control", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "3 Years", 
        "verification_date": "February 2014"
    }
}